IZOBLOK Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 2/6
IZOBLOK's earnings have been declining at an average annual rate of -12.2%, while the Chemicals industry saw earnings growing at 21.3% annually. Revenues have been growing at an average rate of 2.7% per year. IZOBLOK's return on equity is 16.5%, and it has net margins of 5%.
Key information
-12.2%
Earnings growth rate
-12.2%
EPS growth rate
| Chemicals Industry Growth | 32.6% |
| Revenue growth rate | 2.7% |
| Return on equity | 16.5% |
| Net Margin | 5.0% |
| Next Earnings Update | 24 May 2024 |
Recent past performance updates
Recent updates
IZOBLOK S.A. (WSE:IZB) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Mar 09
IZOBLOK (WSE:IZB) Is Experiencing Growth In Returns On Capital
Feb 20Market Still Lacking Some Conviction On IZOBLOK S.A. (WSE:IZB)
Jan 16Is IZOBLOK (WSE:IZB) Using Too Much Debt?
Dec 09IZOBLOK (WSE:IZB) Is Carrying A Fair Bit Of Debt
Mar 29A Look At The Fair Value Of IZOBLOK S.A. (WSE:IZB)
Feb 03
Revenue & Expenses BreakdownBeta
How IZOBLOK makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Oct 23 | 277 | 14 | 98 | 0 |
| 31 Jul 23 | 270 | 14 | 95 | 0 |
| 30 Apr 23 | 253 | 6 | 91 | 0 |
| 31 Jan 23 | 224 | -6 | 85 | 0 |
| 31 Oct 22 | 201 | -16 | 82 | 0 |
| 31 Jul 22 | 175 | -24 | 77 | 0 |
| 30 Apr 22 | 160 | -25 | 74 | 0 |
| 31 Jan 22 | 163 | -22 | 76 | 0 |
| 31 Oct 21 | 171 | -16 | 77 | 0 |
| 31 Jul 21 | 190 | -12 | 79 | 0 |
| 30 Apr 21 | 187 | -11 | 77 | 0 |
| 31 Jan 21 | 171 | -13 | 70 | 0 |
| 31 Oct 20 | 166 | -13 | 69 | 0 |
| 31 Jul 20 | 167 | -10 | 68 | 0 |
| 30 Apr 20 | 185 | -5 | 73 | 0 |
| 31 Jan 20 | 207 | 4 | 86 | 0 |
| 31 Oct 19 | 210 | 4 | 78 | 0 |
| 31 Jul 19 | 213 | 3 | 79 | 0 |
| 30 Apr 19 | 217 | 4 | 81 | 0 |
| 31 Jan 19 | 220 | 3 | 73 | 0 |
| 31 Oct 18 | 225 | 6 | 83 | 0 |
| 31 Jul 18 | 229 | 6 | 83 | 0 |
| 30 Apr 18 | 229 | 3 | 81 | 0 |
| 31 Jan 18 | 224 | 2 | 86 | 0 |
| 31 Oct 17 | 225 | 3 | 82 | 0 |
| 31 Jul 17 | 210 | 4 | 74 | 0 |
| 30 Apr 17 | 180 | 8 | 61 | 0 |
| 31 Jan 17 | 152 | 10 | 44 | 0 |
| 31 Oct 16 | 120 | 8 | 34 | 0 |
| 31 Jul 16 | 96 | 6 | 28 | 0 |
| 30 Apr 16 | 94 | 4 | 25 | 0 |
| 31 Jan 16 | 88 | 6 | 26 | 0 |
| 31 Oct 15 | 85 | 8 | 23 | 0 |
| 31 Jul 15 | 82 | 10 | 18 | 0 |
| 30 Apr 15 | 80 | 11 | 18 | 0 |
| 31 Jan 15 | 77 | 9 | 5 | 0 |
| 31 Oct 14 | 74 | 8 | 6 | 0 |
| 31 Jul 14 | 76 | 9 | 7 | 0 |
| 30 Apr 14 | 76 | 8 | 9 | 0 |
| 31 Jan 14 | 75 | 9 | 15 | 0 |
| 31 Oct 13 | 73 | 9 | 14 | 0 |
| 31 Jul 13 | 66 | 6 | 16 | 0 |
Quality Earnings: IZB has high quality earnings.
Growing Profit Margin: IZB became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IZB's earnings have declined by 12.2% per year over the past 5 years.
Accelerating Growth: IZB has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: IZB has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-5%).
Return on Equity
High ROE: IZB's Return on Equity (16.5%) is considered low.